X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Aventis Pharma with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SANOFI INDIA vs LUPIN LTD - Comparison Results

SANOFI INDIA    Change

Sanofi India (the erstwhile Aventis Pharma), the 60% subsidiary of Sanofi-Aventis SA, France, is one of the largest pharma MNCs in India with a turnover of over Rs 13.2 bn in CY11. Domestic sales constituted 81% of total sales in CY11 and exports con... More

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SANOFI INDIA LUPIN LTD SANOFI INDIA/
LUPIN LTD
 
P/E (TTM) x 33.4 20.0 166.8% View Chart
P/BV x 6.4 2.7 234.5% View Chart
Dividend Yield % 1.4 0.9 153.5%  

Financials

 SANOFI INDIA   LUPIN LTD
EQUITY SHARE DATA
    SANOFI INDIA
Dec-16
LUPIN LTD
Mar-17
SANOFI INDIA/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs4,5601,750 260.6%   
Low Rs4,4001,384 318.0%   
Sales per share (Unadj.) Rs1,028.5387.4 265.5%  
Earnings per share (Unadj.) Rs129.056.6 227.7%  
Cash flow per share (Unadj.) Rs186.076.8 242.0%  
Dividends per share (Unadj.) Rs68.007.50 906.7%  
Dividend yield (eoy) %1.50.5 317.1%  
Book value per share (Unadj.) Rs753.6298.9 252.1%  
Shares outstanding (eoy) m23.03451.58 5.1%   
Bonus/Rights/Conversions -ESOPS-  
Price / Sales ratio x4.44.0 107.7%   
Avg P/E ratio x34.727.7 125.6%  
P/CF ratio (eoy) x24.120.4 118.1%  
Price / Book Value ratio x5.95.2 113.4%  
Dividend payout %52.713.2 398.2%   
Avg Mkt Cap Rs m103,174707,513 14.6%   
No. of employees `0003.616.8 21.6%   
Total wages/salary Rs m3,59228,495 12.6%   
Avg. sales/employee Rs Th6,537.710,418.3 62.8%   
Avg. wages/employee Rs Th991.41,697.0 58.4%   
Avg. net profit/employee Rs Th819.81,523.0 53.8%   
INCOME DATA
Net Sales Rs m23,686174,943 13.5%  
Other income Rs m7081,065 66.5%   
Total revenues Rs m24,394176,008 13.9%   
Gross profit Rs m5,28144,931 11.8%  
Depreciation Rs m1,3139,122 14.4%   
Interest Rs m151,525 1.0%   
Profit before tax Rs m4,66135,349 13.2%   
Minority Interest Rs m0-72 0.0%   
Prior Period Items Rs m083 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,6919,785 17.3%   
Profit after tax Rs m2,97025,575 11.6%  
Gross profit margin %22.325.7 86.8%  
Effective tax rate %36.327.7 131.1%   
Net profit margin %12.514.6 85.8%  
BALANCE SHEET DATA
Current assets Rs m15,673119,542 13.1%   
Current liabilities Rs m6,67861,206 10.9%   
Net working cap to sales %38.033.3 113.9%  
Current ratio x2.32.0 120.2%  
Inventory Days Days7676 100.0%  
Debtors Days Days2290 24.8%  
Net fixed assets Rs m8,098131,660 6.2%   
Share capital Rs m230903 25.5%   
"Free" reserves Rs m17,088134,073 12.7%   
Net worth Rs m17,356134,976 12.9%   
Long term debt Rs m056,478 0.0%   
Total assets Rs m25,400266,073 9.5%  
Interest coverage x311.724.2 1,289.5%   
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.90.7 141.8%   
Return on assets %11.810.2 115.4%  
Return on equity %17.118.9 90.3%  
Return on capital %26.919.3 139.8%  
Exports to sales %24.50-   
Imports to sales %28.00-   
Exports (fob) Rs m5,801NA-   
Imports (cif) Rs m6,627NA-   
Fx inflow Rs m7,14581,885 8.7%   
Fx outflow Rs m6,84621,506 31.8%   
Net fx Rs m29960,378 0.5%   
CASH FLOW
From Operations Rs m3,22641,148 7.8%  
From Investments Rs m-1,555-25,287 6.1%  
From Financial Activity Rs m-1,8184,332 -42.0%  
Net Cashflow Rs m-14720,193 -0.7%  

Share Holding

Indian Promoters % 0.0 46.6 -  
Foreign collaborators % 60.4 0.2 30,200.0%  
Indian inst/Mut Fund % 14.4 11.3 127.4%  
FIIs % 14.6 31.9 45.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 10.5 10.1 104.0%  
Shareholders   15,184 98,259 15.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SANOFI INDIA With:   IPCA LABS  GSK PHARMA  PLETHICO PHARMA  MERCK LTD  NOVARTIS  

Compare SANOFI INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Indian Indices Trade Marginally Lower; Energy Stocks Witness Losses(11:30 am)

Share markets in India are presently trading marginally lower. Sectoral indices are trading on a mixed note with stocks in the energy sector and auto sector witnessing maximum selling pressure.

Related Views on News

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

More Views on News

Most Popular

The Foundation for Sensex 100,000 is Laid(The 5 Minute Wrapup)

Feb 17, 2018

Top three reasons for Tanushree's presentation at Equitymaster Conference to be centered around a possible 30% correction.

The Era of Easy Money is Coming to an End. What Happens Now?(Vivek Kaul's Diary)

Feb 9, 2018

The easy money policy of the Federal Reserve of the United States, which drove up stock markets all over the world, is ending, with the Federal Reserve looking to shrink its balance sheet.

The Markets Want Your Money. Don't Give It to Them.(Smart Contrarian)

Feb 9, 2018

MFs are having a gala time taking money from over-eager investors and funneling it into equities. Smart investors, though, know better than to do that.

The Big Gamble(The Honest Truth)

Feb 15, 2018

Once you accept the fact that elections are round the corner and that this budget is geared to reach a 40% target, everything makes sense.

NPAs Set to Rise Further with New RBI Rules(Chart Of The Day)

Feb 15, 2018

The RBI overhauls bad loan framework. Banks may come under additional pressure due to rising NPAs and increased provisioning.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SANOFI INDIA SHARE PRICE


Feb 22, 2018 12:59 PM

TRACK SANOFI INDIA

  • Track your investment in SANOFI INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SANOFI INDIA 8-QTR ANALYSIS

COMPARE SANOFI INDIA WITH

MARKET STATS